GLP-1 Market
LLY $1406.29 ▼ -1.8% NVO $40.70 ▼ -2.2% PFE $28.41 ▼ -1.6% VKTX $26.65 ▼ -0.6% KLRA $12.08 ▼ -3.9% GPCR $18.06 ▼ -2.7% RHHBY $60.95 ▲ +1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Standard Iron

Company
Universitas Padjadjaran
Mechanism
Mechanism not yet reported
Route
Oral
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Nov 17, 2026

Trial details
  • Completed NCT NCT03656172

    Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor

    Institut Cancerologie de l'Ouest 51 participants Est. completion 2020-05-11 1 site
    Other conditions: Solid Tumor, Adult, Anemia Deficiency
    View official trial listing →
  • Status unknown NCT NCT03828708

    Early Iron Exposure on the Gut Microbiota in Young Infants

    Not yet reported University of Colorado, Denver 30 participants Est. completion 2024-05 1 site Stand-alone
    Other conditions: Infant Development
    View official trial listing →
  • Completed NCT NCT04691843

    Iron Supplementation and Neurodevelopmental Outcome in ELGANs

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 51 participants Est. completion 2024-08-31 1 site
    Other conditions: Iron-deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT05119166

    International Milk Composition (IMiC) Consortium

    University of Manitoba 1000 participants Est. completion 2026-10-30 1 site
    Other conditions: Infant Growth, Maternal Health, Infant Nutrition
    View official trial listing →
  • Status unknown NCT NCT05740462

    Hydroponic Fortification and Dietary App Effect on Nutrients Level (Harvest)

    Not yet reported Quadram Institute Bioscience 52 participants Est. completion 2025-09-01 1 site
    Other conditions: Iron Deficiency (Without Anemia), B12 Deficiency Vitamin
    View official trial listing →
  • Status unknown NCT NCT05882955

    Designing a Mixed-initiative Recipe Recommender App for Vegan and Vegetarian Sub-groups

    Not yet reported Universitaire Ziekenhuizen KU Leuven 52 participants Est. completion 2024-12-31 1 site
    Other conditions: Mobile Applications
    View official trial listing →
  • Completed NCT NCT06875947

    EFFECTS of MICRONIZED MORINGA OLEIFERA LEAF POWDER on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA

    Not yet reported Universitas Padjadjaran 59 participants Est. completion 2026-05-31 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia of Pregnancy, Pregnancy Complications, Inflammation, Moringa Oleifera, Cytokines (IL-1, IL-6), Hepcidin
    View official trial listing →
  • Completed NCT NCT06888232

    Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients

    Not yet reported Muhammad Aamir Latif 121 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Thalassemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Standard Iron, Standard Iron Tablets (Fe + Folic Acid), Tambah Darah

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.